Clarient Licenses Biomarker IP from Insight Genetics
May 31, 2012
Clarient Licenses Biomarker IP from Insight Genetics
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Kindstar to Offer Insight Genetics' ALK Lung Cancer Screening Test
June 1, 2012 / GenomeWeb Daily News - Dx Focus: Clarient to Offer Qiagen Therascreen KRAS Test as Erbitux CDx
January 31, 2013 / PCR Insider - Clarient to Offer Qiagen's Therascreen KRAS Assay as CDx for Erbitux
January 30, 2013 / GenomeWeb Daily News - VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News - Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News